We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-6 of 6

Biotech Life Sciences trade mission to Australia announced
  • Shook Hardy & Bacon LLP
  • USA, Australia
  • June 21 2012

The U.S. Department of Commerce, International Trade Administration and U.S. and Foreign Commercial Service have announced an October 29-November 2, 2012, Biotech Life Sciences trade mission to Australia

Australia and New Zealand to form joint drug, medical-device regulatory agency
  • Shook Hardy & Bacon LLP
  • New Zealand, Australia
  • June 30 2011

The Australian and New Zealand governments have reportedly developed a five-year plan to create a joint agency that will regulate medicines, medical devices and new medical interventions, such as cellular therapy

Australian court finds human gene mutation to be patentable
  • Shook Hardy & Bacon LLP
  • Australia, USA
  • September 11 2014

A full panel of the Federal Court of Australia has upheld its earlier ruling that an isolated but naturally occurring nucleic acid, BRCA1, can be

Universities abroad experiment with no-fee licensing to drive biotech partnerships
  • Shook Hardy & Bacon LLP
  • Australia, Canada, European Union, United Kingdom, USA
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

Thomas T. Moga
  • Shook Hardy & Bacon LLP